Aliskiren Study of Safety and Efficacy in Senior Hypertensives
Status:
Withdrawn
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the blood pressure lowering efficacy of aliskiren, a
combination of aliskiren plus amlodipine, and ramipril in elderly patients with mild to
moderate hypertension. It will also compare the long-term safety of an aliskiren-based
regimen to a ramipril-based regimen